Abstrakt

Przypisy

• 1. Ali S.M., Chee S.K., Yuen G.Y., Olivo M.: Hypericin induced deathreceptor mediated apoptosis in photo activated tumor cells. Int. J.Mol. Med., 2002; 9: 601-616
  Google Scholar
• 2. Ali S.M., Olivo M.: Bio-distribution and subcellular localizationof Hypericin and its role in PDT induced apoptosis in cancer cells.Int. J. Oncol., 2002; 21: 531-540
  Google Scholar
• 3. Ali S.M., Olivo M., Yuen G.Y., Chee S.K.: Induction of apoptosisby Hypericin through activation of caspase-3 in human carcinomacells. Int. J. Mol. Med., 2001; 8: 521-530
  Google Scholar
• 4. Allman R., Cowburn P., Mason M.: Effect of photodynamic therapyin combination with ionizing radiation on human squamous cell carcinomacell lines of the head and neck. Br. J. Cancer, 2000; 83: 655-661
  Google Scholar
• 5. Batlle A.M.: Porphyrins, porphyrias, cancer and photodynamictherapy – a model for carcinogenesis. J. Photochem. Photobiol. B.,1993; 20: 5-22
  Google Scholar
• 6. Betz C.S., Rauschning W., Stranadko E.P., Riabov M.V., VolginV.N., Albrecht V., Nifantiev N.E., Hopper C.: Long-term outcomesfollowing foscan®-PDT of basal cell carcinomas. Lasers Surg. Med.,2012; 44: 533-540
  Google Scholar
• 7. Biel M.A.: Photodynamic therapy treatment of early oral and laryngealcancers. Photochem. Photobiol., 2007; 83: 1063-1068
  Google Scholar
• 8. Breen P., Joseph N., Thompson K., Kraveka J.M., Gudz T.I., Li L.,Rahmaniyan M., Bielawski J., Pierce J.S., van Buren E., Bhatti G., SeparovicD.: Dihydroceramide desaturase knockdown impacts sphingolipidsand apoptosis after photodamage in human head and necksquamous carcinoma cells. Anticancer Res., 2013; 33: 77-84
  Google Scholar
• 9. Canavesi C., Cassarly W.J., Foster T.H., Rolland J.P.: Lightpipe devicefor delivery of uniform illumination for photodynamic therapyof the oral cavity. Appl. Opt., 2011; 50: 2322-2325
  Google Scholar
• 10. Chao Y.K., Chan S.C., Chang H.K., Liu Y.H., Wu Y.C., Hsieh M.J.,Tseng C.K., Liu H.P.: Salvage surgery after failed chemoradiotherapyin squamous cell carcinoma of the esophagus. Eur. J. Surg. Oncol.,2009; 35: 289-294
  Google Scholar
• 11. Chung P.S., He P., Shin J.I., Hwang H.J., Lee S.J., Ahn J.C.: Photodynamictherapy with 9-hydroxypheophorbide a on AMC-HN-3human head and neck cancer cells: induction of apoptosis via photoactivationof mitochondria and endoplasmic reticulum. CancerBiol. Ther., 2009: 8: 1343-1351
  Google Scholar
• 12. Chung P.S., Kim H.G., Rhee C.K., Saxton R.E.: Anticancer effectof combined intratumor cisplatin injection and interstitial KTP lasertherapy on xenografted squamous cell carcinoma. J. Clin. LaserMed. Surg., 2003; 21: 23-27
  Google Scholar
• 13. Civantos F.: Photodynamic therapy for head and neck lesions inthe subtropics. J. Natl. Compr. Canc. Netw., 2012; 10 (Suppl. 2): S65-S68
  Google Scholar
• 14. Cole C.D., Liu J.K., Sheng X., Chin S.S., Schmidt M.H., Weiss M.H.,Couldwell W.T.: Hypericin-mediated photodynamic therapy of pituitarytumors: preclinical study in a GH4C1 rat tumor model. J.Neurooncol., 2008; 87: 255-261
  Google Scholar
• 15. Copper M.P., Tan I.B., Oppelaar H., Ruevekamp M.C., StewartF.A.: Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy inearly-stage squamous cell carcinoma of the head and neck. Arch.Otolaryngol. Head Neck Surg., 2003; 129: 709-711
  Google Scholar
• 16. Davis P.D., Dougherty G.J., Blakey D.C., Galbraith S.M., Tozer G.M.,Holder A.L., Naylor M.A., Nolan J., Stratford M.R., Chaplin D.J., HillS.A.: ZD6126: a novel vascular-targeting agent that causes selectivedestruction of tumor vasculature. Cancer Res., 2002; 62, 7247-7253
  Google Scholar
• 17. de Visscher S.A., Dijkstra P.U., Tan I.B., Roodenburg J.L., WitjesM.J.: mTHPC mediated photodynamic therapy (PDT) of squamouscell carcinoma in the head and neck: a systematic review. Oral Oncol.,2013; 49: 192-210
  Google Scholar
• 18. Dilkes M.G., Benjamin E., Ovaisi S., Banerjee A.S.: Treatmentofprimary mucosal head and neck squamous cell carcinoma usingphotodynamic therapy: results after 25 treated cases. J. Laryngol.Otol., 2003; 117: 713-717
  Google Scholar
• 19. Fang X., Wu P., Li J., Qi L., Tang Y., Jiang W., Zhao S.: Combinationof apoptin with photodynamic therapy induces nasopharyngeal carcinomacell death in vitro and in vivo. Oncol. Rep., 2012; 28: 2077-2082
  Google Scholar
• 20. Flatscher K.: Immune responses to photodynamic therapy, influenceof PDT on the functional characteristics of dendritic cells.V.D.M. Verlag, 2009; 1: 5-35
  Google Scholar
• 21. Fornalski J.: Terapia fotodynamiczna – jej oddiaływanie i zastosowaniew dermatologii. Borgis – Nowa Medycyna, 2006; 4: 71-74
  Google Scholar
• 22. Gaál M., Otrosinka S., Baltás E., Ocsai H., Oláh J., Kemény L., GyulaiR.: Photodynamic therapy of non-melanoma skin cancer withmethyl aminolaevulinate is associated with less pain than with aminolaevulinicacid. Acta Derm. Venereol., 2012; 92: 173-175
  Google Scholar
• 23. Garg A.D., Bose M., Ahmed M.I., Bonass W.A., Wood S.R.: In vitrostudies on erythrosine-based photodynamic therapy of malignantand pre-malignant oral epithelial cells. PLoS One, 2012; 7: e34475
  Google Scholar
• 24. Gerber-Leszczyszyn H., Ziółkowski P., Marszalik P.: Photodynamictherapy of head and neck tumors and non-tumor like disorders.Otolaryngol. Pol., 2004; 58: 339-343
  Google Scholar
• 25. Gil M., Bieniasz M., Seshadri M., Fisher D., Ciesielski M.J., ChenY., Pandey R.K., Kozbor D.: Photodynamic therapy augments the efficacyof oncolytic vaccinia virus against primary and metastatictumours in mice. Br. J. Cancer, 2011; 105: 1512-1521
  Google Scholar
• 26. Gyenge E.B., Forny P., Lüscher D., Laass A., Walt H., Maake C.:Effects of hypericin and a chlorin based photosensitizer alone or incombination in squamous cell carcinoma cells in the dark. PhotodiagnosisPhotodyn. Ther., 2012; 9: 321-331
  Google Scholar
• 27. He P., Ahn J.C., Shin J.I., Hwang H.J., Kang J.W., Lee S.J., ChungP.S.: Enhanced apoptotic effect of combined modality of 9-hydroxypheophorbidealpha-mediated photodynamic therapy andcarboplatin on AMC-HN-3 human head and neck cancer cells. Oncol.Rep., 2009; 21: 329-334
  Google Scholar
• 28. Hicks W.L.Jr., Loree T.R., Garcia R.I., Maamoun S., Marshall D.,Orner J.B., Bakamjian V.Y., Shedd D.P.: Squamous cell carcinoma ofthe floor of mouth: a 20-year review. Head Neck, 1997; 19: 400-405
  Google Scholar
• 29. Hong W.K., Lippman S.M., Itri L.M., Karp D.D., Lee J.S., ByersR.M., Schantz S.P., Kramer A.M., Lotan R., Peters L.J., Dimery I.W.,Brown B.W., Goepfert H.: Prevention of second primary tumors withisotretinoin in squamous-cell carcinoma of the head and neck. N.Engl. J. Med., 1990; 323: 795-801
  Google Scholar
• 30. Hopper C.: Photodynamic therapy: a clinical reality in the treatmentof cancer. Lancet Oncol., 2000; 1: 212-219
  Google Scholar
• 31. Hopper C., Kübler A., Lewis H., Tan I.B., Putnam G.: mTHPCmediatedphotodynamic therapy for early oral squamous cell carcinoma.Int. J. Cancer, 2004; 111: 138-146
  Google Scholar
• 32. Hung H.I., Schwartz J.M., Maldonado E.N., Lemasters J.J., NieminenA.L.: Mitoferrin-2-dependent mitochondrial iron uptakesensitizes human head and neck squamous carcinoma cells to photodynamictherapy. J. Biol. Chem., 2013; 288: 677-686
  Google Scholar
• 33. Indrasari S.R., Timmermans A.J., Wildeman M.A., KarakullukcuM.B., Herdini C., Hariwiyanto B., Tan I.B.: Remarkable response tophotodynamic therapy in residual T4N0M0 nasopharyngeal carcinoma:a case report. Photodiagnosis Photodyn. Ther., 2012; 9: 319-320
  Google Scholar
• 34. Jäger H.R., Taylor M.N., Theodossy T., Hopper C.: MR imagingguidedinterstitial photodynamic laser therapy for advanced headand neck tumors. AJNR Am. J. Neuroradiol., 2005; 26: 1193-1200
  Google Scholar
• 35. Jerjes W., Hamdoon Z., Hopper C.: Photodynamic therapy in themanagement of potentially malignant and malignant oral disorders.Head Neck Oncol., 2012; 4: 16
  Google Scholar
• 36. Jerjes W., Upile T., Hamdoon Z., Abbas S., Akram S., Mosse C.A.,Morley S., Hopper C.: Photodynamic therapy: the minimally invasivesurgical intervention for advanced and/or recurrent tongue basecarcinoma. Lasers Surg. Med., 2011; 43: 283-292
  Google Scholar
• 37. Jerjes W., Upile T., Hamdoon Z., Mosse C.A., Morcos M., HopperC.: Photodynamic therapy outcome for T1/T2 N0 oral squamous cellcarcinoma. Lasers Surg. Med., 2011; 43: 463-469
  Google Scholar
• 38. Jerjes W., Upile T., Radhi H., Hopper C.: Photodynamic therapyand end-stage tongue base cancer: short communication. Head NeckOncol., 2011; 3: 49
  Google Scholar
• 39. Jerjes W., Upile T., Radhi H., Hopper C.: Photodynamic therapyvs. photochemical internalization: the surgical margin. Head NeckOncol., 2011, 3: 53
  Google Scholar
• 40. Karakullukcu B., Stoker S.D., Wildeman A.P., Copper M.P., WildemanM.A., Tan I.B.: A matched cohort comparison of mTHPC-mediatedphotodynamic therapy and trans-oral surgery of early stageoral cavity squamous cell cancer. Eur. Arch. Otorhinolaryngol., 2013;270: 1093-1097
  Google Scholar
• 41. Karakullukcu B., van Oudenaarde K., Copper M.P., Klop W.M.,van Veen R., Wildeman M., Tan I.B.: Photodynamic therapy ofearly stage oral cavity and oropharynx neoplasms: an outcomeanalysis of 170 patients. Eur. Arch. Otorhinolaryngol., 2011; 268:281-288
  Google Scholar
• 42. Lee J., Moon C.: Current status of experimental therapeutics forhead and neck cancer. Exp. Biol. Med., 2011; 236: 375-389
  Google Scholar
• 43. Lemasters J.J., Nieminen A.L., Qian T., Trost L.C., Elmore S.P.,Nishimura Y., Crowe R.A., Cascio W.E., Bradham C.A., Brenner D.A.,Herman B.: The mitochondrial permeability transition in cell death:a common mechanism in necrosis, apoptosis and autophagy. Biochim.Biophys. Acta, 1998; 1366: 177-196
  Google Scholar
• 44. Li P., Zhou G., Zhu X., Li G., Yan P., Shen L., Xu Q., HamblinM.R.: Photodynamic therapy with hyperbranched poly(ether-ester)chlorin(e6) nanoparticles on human tongue carcinoma Cal-27 cells.Photodiagnosis Photodyn. Ther., 2012; 9: 76-82
  Google Scholar
• 45. Lim S.H., Lee H.B., Ho A.S.: A new naturally derived photosensitizerand its phototoxicity on head and neck cancer cells. Photochem.Photobiol., 2011; 87: 1152-1158
  Google Scholar
• 46. Liu T.C., Hwang T., Park B.H., Bell J., Kirn D.H.: The targetedoncolytic poxvirus JX-594 demonstrates antitumoral, antivascular,and anti-HBV activities in patients with hepatocellular carcinoma.Mol. Ther., 2008; 16: 1637-1642
  Google Scholar
• 47. Lodi G., Sardella A., Bez C., Demarosi F., Carrassi A.: Interventionsfor treating oral leukoplakia. Cochrane Database Syst. Rev.,2004; 3: CD001829
  Google Scholar
• 48. Lorenz K.J., Maier H.: Photodynamic therapy with metatetrahydroxyphenylchlorin(Foscan) in the management of squamous cellcarcinoma of the head and neck: experience with 35patients. Eur.Arch. Otorhinolaryngol., 2009; 266: 1937-1944
  Google Scholar
• 49. Lou P.J., Jäger H.R., Jones L., Theodossy T., Bown S.G., Hopper C.:Interstitial photodynamic therapy as salvage treatment for recurrenthead and neck cancer. Br. J. Cancer, 2004; 91: 441-446
  Google Scholar
• 50. Martín E.G., Fernández Tirado F.J.: Periocular basal cell carcinomatreatment tendencies. Arch. Soc. Esp. Oftalmol., 2010; 85: 261-262
  Google Scholar
• 51. Master A., Malamas A., Solanki R., Clausen D.M., Eiseman J.L.,Gupta A.S.: A cell-targeted photodynamic nanomedicine strategy forhead and neck cancers. Mol. Pharm., 2013; 10: 1988-1997
  Google Scholar
• 52. Mo W., Rohrbach D., Sunar U.: Imaging a photodynamic therapyphotosensitizer in vivo with a time-gated fluorescence tomographysystem. J. Biomed. Opt., 2012; 17: 071306
  Google Scholar
• 53. Moghissi K.: Where does photodynamic therapy fit in the esophagealcancer treatment jigsaw puzzle? J. Natl. Compr. Canc. Netw.,2012; 10 (Suppl. 2): S52-S55
  Google Scholar
• 54. Nava H.R., Allamaneni S.S., Dougherty T.J., Cooper M.T., TanW., Wilding G., Henderson B.W.: Photodynamic therapy (PDT) usingHPPH for the treatment of precancerous lesions associated with Barrett’sesophagus. Lasers Surg. Med., 2011; 43: 705-712
  Google Scholar
• 55. Nyst H.J., van Veen R.L., Tan I.B., Peters R., Spaniol S., RobinsonD.J., Stewart F.A., Levendag P.C., Sterenborg H.J.: Performance of adedicated light delivery and dosimetry device for photodynamictherapy of nasopharyngeal carcinoma: phantom and volunteer experiments.Lasers Surg. Med., 2007; 39: 647-653
  Google Scholar
• 56. Nyst H.J., Wildeman M.A., Indrasari S.R., Karakullukcu B., vanVeen R.L., Adham M., Stewart F.A., Levendag P.C., Sterenborg H.J.,Tan I.B.: Temoporfin mediated photodynamic therapy in patientswith local persistent and recurrent nasopharyngeal carcinoma aftercurative radiotherapy: a feasibility study. Photodiagnosis Photodyn.Ther., 2012; 9: 274-281
  Google Scholar
• 57. Park B.H., Hwang T., Liu T.C., Sze D.Y., Kim J.S., Kwon H.C., OhS.Y., Han S.Y.,Yoon J.H., Hong S.H., Moon A., Speth K., Park C., AhnY.J., Daneshmand M., Rhee B.G., Pinedo H.M., Bell J.C., Kirn D.H.:Use of a targeted oncolytic poxvirus, JX-594, in patients with refractoryprimary or metastatic liver cancer: a phase I trial. LancetOncol., 2008; 9: 533-542
  Google Scholar
• 58. Park J.H., Moon Y.H., Kim D.J., Kim S.A., Lee J.B., Ahn S.G., YoonJ.H.: Photodynamic therapy with hexenyl ester of 5-aminolevulinicacid induces necrotic cell death in salivary gland adenocarcinomacells. Oncol. Rep., 2010; 24: 177-181
  Google Scholar
• 59. Peng Q., Warloe T., Berg K., Moan J., Kongshaug M., GierckskyK.E., Nesland J.M.: 5-Aminolevulinic acid-based photodynamictherapy. Clinical research and future challenges. Cancer, 1997; 79:2282-2308
  Google Scholar
• 60. Quon H., Grossman C.E., Finlay J.C., Zhu T.C., Clemmens C.S., MalloyK.M., Busch T.M.: Photodynamic therapy in the management ofpre-malignant head and neck mucosal dysplasia and microinvasivecarcinoma. Photodiagnosis Photodyn. Ther., 2011; 8: 75-85
  Google Scholar
• 61. Rigual N.R., Thankappan K., Cooper M., Sullivan M.A., DoughertyT., Popat S.R., Loree T.R., Biel M.A., Henderson B.: Photodynamictherapy for head and neck dysplasia and cancer. Arch. Otolaryngol.Head Neck Surg., 2009; 135: 784-788
  Google Scholar
• 62. Ross A.H., Kennedy C.T., Collins C., Harrad R.A.: The use of imiquimodin the treatment of periocular tumours. Orbit, 2010; 29:83-87
  Google Scholar
• 63. Sankaranarayanan R., Mathew B., Varghese C., Sudhakaran P.R.,Menon V., Jayadeep A., Nair M.K., Mathews C., Mahalingam T.R.,Balaram P., Nair P.P.: Chemoprevention of oral leukoplakia with vitaminA and beta carotene: an assessment. Oral Oncol., 1997; 33:231-236
  Google Scholar
• 64. Separovic D., Breen P., Joseph N., Bielawski J., Pierce J.S., vanBuren E., Gudz T.I.: siRNA-mediated down-regulation of ceramidesynthase 1 leads to apoptotic resistance in human head and necksquamous carcinoma cells after photodynamic therapy. AnticancerRes., 2012; 32: 2479-2485
  Google Scholar
• 65. Seshadri M., Mazurchuk R., Spernyak J.A., Bhattacharya A., RustumY.M., Bellnier D.A.: Activity of the vascular-disrupting agent5,6-dimethylxanthenone-4-acetic acid against human head and neckcarcinoma xenografts. Neoplasia, 2006; 8: 534-542
  Google Scholar
• 66. Shafirstein G.G., Friedman A., Siegel E., Moreno M., BäumlerW., Fan C.Y., Morehead K., Vural E., Stack B.C.Jr., Suen J.Y.: Using5-aminolevulinic acid and pulsed dye laser for photodynamic treatmentof oral leukoplakia. Arch. Otolaryngol. Head Neck Surg., 2011;137: 1117-1123
  Google Scholar
• 67. Sibata C.H., Colussi V.C., Oleinick N.L., Kinsella T.J.: Photodynamictherapy in oncology. Expert Opin. Pharmacother., 2001; 2: 917-927
  Google Scholar
• 68. Steinbauer J.M., Schreml S., Babilas P., Zeman F., Karrer S.,Landthaler M., Szeimies R.M.: Topical photodynamic therapy withporphyrin precursors – assessment of treatment-associated pain ina retrospective study. Photochem. Photobiol. Sci., 2009; 8: 1111-1116
  Google Scholar
• 69. Sunar U., Rohrbach D., Rigual N., Tracy E., Keymel K., CooperM.T., Baumann H., Henderson B.H.: Monitoring photobleaching andhemodynamic responses to HPPH-mediated photodynamic therapyof head and neck cancer: a case report. Opt. Express, 2010; 18:14969-14978
  Google Scholar
• 70. Surrenti T., De Angelis L., Di Cesare A., Fargnoli M.C., Peris K.:Efficacy of photodynamic therapy with methyl aminolevulinate inthe treatment of superficial and nodular basal cell carcinoma: anopen-label trial. Eur. J. Dermatol., 2007; 17: 412-415
  Google Scholar
• 71. Tachimori Y., Kanamori N., Uemura N., Hokamura N., Igaki H.,Kato H.: Salvage esophagectomy after high-dose chemoradiotherapyfor esophageal squamous cell carcinoma. J. Thorac. Cardiovasc.Surg., 2009; 137: 49-54
  Google Scholar
• 72. Togsverd-Bo K., Hædersdal M., Wulf H.C.: Photodynamic therapyfor tumors on the eyelid margins. Arch. Dermatol., 2009; 145: 944-947
  Google Scholar
• 73. Uppal A., Jain B., Gupta P.K., Das K.: Photodynamic action ofRose Bengal silica nanoparticle complex on breast and oral cancercell lines. Photochem. Photobiol., 2011; 87: 1146-1151
  Google Scholar
• 74. Wang I., Bauer B., Andersson-Engels S., Svanberg S., Svanberg K.:Photodynamic therapy utilizing topical delta-aminolevulinic acid innon-melanoma skin malignancies of the eyelid and the periocularskin. Acta Ophthalmol. Scand., 1999; 77: 182-188
  Google Scholar
• 75. Wang X., Guo Y., Yang S., Wang C., Fu X., Wang J., Mao Y., ZhangJ., Li Y.: Cellular and molecular mechanisms of photodynamic hypericintherapy for nasopharyngeal carcinoma cells. J. Pharmacol.Exp. Ther., 2010; 334: 847-853
  Google Scholar
• 76. Waterfield E.M., Renke M.E., Smits C.B., Gervais M.D., Bower R.D.,Stonefield M.S., Levy J.G.: Wavelength-dependent effects of benzoporphyrinderivative monoacid ring A in vivo and in vitro. Photochem.Photobiol., 1994; 60: 383-387
  Google Scholar
• 77. Wildeman M.A., Nyst H.J., Karakullukcu B., Tan B.I.: Photodynamictherapy in the therapy for recurrent/persistent nasopharyngealcancer. Head Neck Oncol., 2009; 1: 40
  Google Scholar
• 78. Yano T., Muto M., Yoshimura K., Niimi M., Ezoe Y., Yoda Y., YamamotoY., Nishisaki H., Higashino K., Iishi H.: Phase I study of photodynamictherapy using talaporfin sodium and diode laser for localfailure after chemoradiotherapy for esophageal cancer. Radiat.Oncol., 2012; 7: 113
  Google Scholar
• 79. Yow C.M., Chen J.Y., Mak N.K., Cheung N.H., Leung A.W.: Cellularuptake, subcellular localization and photodamaging effect of temoporfin(mTHPC) in nasopharyngeal carcinoma cells: comparisonwith hematoporphyrin derivative. Cancer Lett., 2000; 157: 123-131
  Google Scholar
• 80. Yow C.M., Mak N.K., Szeto S., Chen J.Y., Lee Y.L., Cheung N.H.,Huang D.P., Leung A.W.: Photocytotoxic and DNA damaging effectof temoporfin (mTHPC) and merocyanine 540 (MC540) on nasopharyngealcarcinoma cell. Toxicol. Lett., 2000; 115: 53-61
  Google Scholar
• 81. Ziółkowski P., Symonowicz K., Osiecka B.J., Rabczyński J., GerberJ.: Photodynamic treatment of epithelial tissue derived from patientswith endometrial cancer: a contribution to the role of lamininand epidermal growth factor receptor in photodynamic therapy. J.Biomed. Opt., 1999; 4: 272-275
  Google Scholar

Pełna treść artykułu